Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-19

Clinical Trial Update: Procalcitonin as a Marker for the Length of Antibiotic Treatment in Peritonitis and Intra-abdominal Infections

View source ↗

Summary

A completed trial assessed whether procalcitonin can guide antibiotic duration in secondary or tertiary peritonitis and intra-abdominal infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Lausanne Hospitals | Conditions: Secondary or Tertiary Peritonitis | Status: COMPLETED